{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:03:55Z","timestamp":1775581435364,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YFQ0030"],"award-info":[{"award-number":["2021YFQ0030"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Mycobacterium houstonense<\/jats:italic> is a rapidly growing mycobacterium (RGM) that belongs to the unnamed third biovariant complex of the <jats:italic>Mycobacterium fortuitum<\/jats:italic> group, which is rarely responsible for human infection. Approximately 76% of infections caused by the <jats:italic>M. fortuitum<\/jats:italic> group occur after open fractures or skin, soft tissue, bone, or puncture wounds. To date, only a few cases of human infectious disease caused b<jats:italic>y M. houstonense<\/jats:italic> have been reported worldwide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a case of a 26-year-old man with a central nervous system (CNS) infection caused by <jats:italic>M. houstonense<\/jats:italic>. The patient was transferred to our hospital because of headaches and muscle strength changes. One month prior to presentation at our hospital, the patient was diagnosed with tuberculous meningitis at the other two hospitals, but his condition did not improve after anti-tuberculous treatment, antibiotics, and anti-viral treatment before admission to our hospital. Lumbar puncture was performed at both previous hospitals, as well as at our hospital; the results consistently indicated high cerebrospinal fluid (CSF) opening pressure. <jats:italic>M. houstonense<\/jats:italic> was detected in the CSF of the second hospital's lumbar puncture by metagenomic next-generation sequencing (mNGS) but was not identified at our hospital. The patient was discharged from our hospital after receiving non-tuberculous mycobacterium (NTM) treatment for 1 month according to the Chinese NTM guidelines. However, the patient died 20 days after discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Since it is difficult to identify <jats:italic>M. houstonense<\/jats:italic>, this is the first case of human CNS infection caused by <jats:italic>M. houstonense<\/jats:italic> in China. This case may be considered by neurologists and infectious physicians when CNS infection does not respond to conventional treatment, especially in the uncommon type of NTM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.908086","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T05:59:55Z","timestamp":1662011995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Central nervous system infection caused by Mycobacterium houstonense: A case report"],"prefix":"10.3389","volume":"13","author":[{"given":"LiXia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FaPing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FengMing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1099\/ijs.0.02743-0","article-title":"Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates","volume":"54","author":"Schinsky","year":"2004","journal-title":"Int J Syst Evol Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/microbiolspec.TNMI7-0027-2016","article-title":"Rapidly growing mycobacteria","volume":"5","author":"Brown-Elliott","year":"2017","journal-title":"Microbiol Spectr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/microorganisms9112345","article-title":"Clinical relevance and environmental prevalence of Mycobacterium fortuitum Group Members. Comment on Mugetti et al. Gene sequencing and phylogenetic analysis: powerful tools for an improved diagnosis of fish mycobacteriosis caused by Mycobacterium fortuitum Group members","volume":"9","author":"Pavlik","year":"2021","journal-title":"Microorganisms"},{"key":"B4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.51620\/0869-2084-2021-66-4-223-228","article-title":"General characteristics, features of cultivation and antibiotic resistance representatives of Mycobacterium fortuitum group representatives (review of literature)","volume":"66","author":"Gerasimova","year":"2021","journal-title":"Klin Lab Diagn."},{"key":"B5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3760\/cma.j.cn112338-20190809-00587","article-title":"Description of epidemic features and control status on tuberculosis in China, 1990\u20132017","volume":"41","author":"Wang XJ Li","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1590\/s1413-86702009000600011","article-title":"Non tuberculous mycobacteria and toxoplasma co-infection of the central nervous system in a patient with AIDS","volume":"13","author":"Sardar","year":"2009","journal-title":"Braz J Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4236\/jtr.2015.32008","article-title":"A Case of meningitis caused by Mycobacterium abscessus in a paediatric patient","volume":"3","author":"Devi","year":"2015","journal-title":"J Tuberculosis Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s1473-3099(08)70127-0","article-title":"Spectrum of CNS disease caused by rapidly growing mycobacteria","volume":"8","author":"Talati","year":"2008","journal-title":"Lancet Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3760\/cma.j.cn112147-20200508-00570","article-title":"\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\u75c5\u8bca\u65ad\u4e0e\u6cbb\u7597\u6307\u5357 (2020 \u5e74\u7248). \u4e2d\u534e\u7ed3\u6838\u548c\u547c\u5438\u6742\u5fd7","volume":"43","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/fpd.2012.1419","article-title":"Nontuberculous mycobacteria in freshwater fish and fish products intended for human consumption","volume":"10","author":"Lorencova","year":"2013","journal-title":"Foodborne Pathog Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3979-2","article-title":"Surgical wound infection following open humeral fracture caused by Mycobacterium houstonense: a case report","volume":"19","author":"Tian","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12879-020-05590-7","article-title":"Endophthalmitis caused by Mycobacterium houstonense: case report","volume":"20","author":"Che","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1128\/cmr.15.4.716-746.2002","article-title":"Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria","volume":"15","author":"Brown-Elliott","year":"2002","journal-title":"Clin Microbiol Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"57537","DOI":"10.18632\/oncotarget.15734","article-title":"The application of IS6110-baced loop-mediated isothermal amplification (LAMP) in the early diagnosis of tuberculous meningitis","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/s0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fmicb.2017.01069","article-title":"Metagenomics: the next culture-independent game changer","volume":"8","author":"Forbes","year":"2017","journal-title":"Front Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e01888","DOI":"10.1128\/mBio.01888-15","article-title":"Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics","volume":"6","author":"Goldberg","year":"2015","journal-title":"MBio."},{"key":"B18","unstructured":"Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing91923\n            NaccacheSN\n            PeggsKS\n            MattesFM\n            PhadkeR\n            GarsonJA\n            GrantP\n          10.1093\/cid\/ciu91225572898Clin Infect Dis.602015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijid.2020.04.048","article-title":"Metagenomic next-generation sequencing (mNGS) in cerebrospinal fluid for rapid diagnosis of Tuberculosis meningitis in HIV-negative population","volume":"96","author":"Yan","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-020-1105-z","article-title":"Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids","volume":"27","author":"Gu","year":"2021","journal-title":"Nat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jinf.2016.08.020","article-title":"The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis","volume":"73","author":"Yu","year":"2016","journal-title":"J Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/microorganisms9122460","article-title":"T-Cell exhaustion in Mycobacterium tuberculosis and nontuberculous mycobacteria infection: pathophysiology and therapeutic perspectives","volume":"9","author":"Lombardi","year":"2021","journal-title":"Microorganisms."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/jcm9051331","article-title":"Characteristics of circulating CD4(+) T cell subsets in patients with Mycobacterium avium complex pulmonary disease","volume":"9","author":"Han","year":"2020","journal-title":"J Clin Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.chom.2008.05.006","article-title":"Mycobacterium tuberculosis and the macrophage: maintaining a balance","volume":"3","author":"Pieters","year":"2008","journal-title":"Cell Host Microbe."},{"key":"B26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0002-9343(94)90326-3","article-title":"Interferon-gamma and host antimicrobial defense: current and future clinical applications","volume":"97","author":"Murray","year":"1994","journal-title":"Am J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1006530","DOI":"10.1371\/journal.ppat.1006530","article-title":"Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection","volume":"13","author":"Sia","year":"2017","journal-title":"PLoS Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","article-title":"Idiopathic CD4 lymphocytopenia","volume":"18","author":"Walker","year":"2006","journal-title":"Curr Opin Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1172\/jci136254","article-title":"Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia","volume":"130","author":"Perez-Diez","year":"2020","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0176342","DOI":"10.1371\/journal.pone.0176342","article-title":"Factors associated with acquired Anti IFN-\u03b3 autoantibody in patients with nontuberculous mycobacterial infection","volume":"12","author":"Phoompoung","year":"2017","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e5479","DOI":"10.7717\/peerj.5479","article-title":"Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand","volume":"6","author":"Kham-Ngam","year":"2018","journal-title":"PeerJ."},{"key":"B34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/aac.35.4.773","article-title":"Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid","volume":"35","author":"Wallace","year":"1991","journal-title":"Antimicrob Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist Updat."},{"key":"B36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000109769","article-title":"Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid","volume":"53","author":"Escribano","year":"2007","journal-title":"Chemotherapy."},{"key":"B37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/infdis\/163.3.598","article-title":"Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum","volume":"163","author":"Wallace","year":"1991","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/aac.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"Wallace","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1128\/aac.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline minocycline and and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1128\/aac.36.1.180","article-title":"Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms","volume":"36","author":"Brown","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1128\/aac.00402-06","article-title":"Intrinsic macrolide resistance in rapidly growing mycobacteria","volume":"50","author":"Nash","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14656566.2020.1740205","article-title":"State-of-the-art treatment strategies for nontuberculous mycobacteria infections","volume":"21","author":"Mu\u00f1oz-Egea","year":"2020","journal-title":"Expert Opin Pharmacother."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.908086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T06:00:00Z","timestamp":1662012000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.908086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":42,"alternative-id":["10.3389\/fneur.2022.908086"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.908086","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"908086"}}